Progressive autosomal recessive ataxia-deafness syndrome Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

💰

1Open funds

Regulatory Watchboard

1 event

Nov 1990

Ornidyl: FDA approved

Treatment of Trypanosoma brucei gambiense infection (sleeping sickness).

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Copay cards

Copay Assistance1

Ornidyl

Hoechst Marion Roussel

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Ornidyl

(Eflornithine HCl)Orphan drug

Hoechst Marion Roussel

Approved Nov 1990

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Progressive autosomal recessive ataxia-deafness syndrome.
Search all trials →

Search clinical trials for Progressive autosomal recessive ataxia-deafness syndrome →

Recent News & Research

No recent news articles indexed yet for Progressive autosomal recessive ataxia-deafness syndrome.
Search PubMed for Progressive autosomal recessive ataxia-deafness syndrome →

Browse all Progressive autosomal recessive ataxia-deafness syndrome news →

Specialist Network

No specialists currently listed for Progressive autosomal recessive ataxia-deafness syndrome.

View all Progressive autosomal recessive ataxia-deafness syndrome specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰